Studies of the brain rather than CSF and blood were preferred, first because the search was for localized early changes in the hippocampus, and second because studies using CSF Tau and Aβ amyloid as inclusion criteria for AD were probably investigating a relatively advanced stage of the AD progression. Here, MAPT is linked to Alzheimer disease.